Attached files
| file | filename |
|---|---|
| EX-5.1 - EXHIBIT 5.1 - Arno Therapeutics, Inc | v432900_ex5-1.htm |
| S-1 - FORM S-1 - Arno Therapeutics, Inc | v432900_s1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Registration Statement of Arno Therapeutics, Inc. on Form S-1 of our report dated March 31, 2015, which included an emphasis of matter paragraph regarding the Company’s ability to continue as a going concern, on the financial statements of Arno Therapeutics, Inc. and to the reference to us under the heading “Experts” in the prospectus.
| /s/ Crowe Horwath LLP | |
| New York, New York | |
| March 11, 2016 |